On October 23, 2012, Amgen (NASDAQ: AMGN) announced financial results for the third quarter of 2012.
On March 15, 2012, Amgen (NASDAQ: AMGN) announced that its Board of Directors declared a $0.36 per share dividend for the second quarter of 2012.
On January 26, 2012, Amgen (NASDAQ: AMGN) reported total revenue increased 3% during the fourth quarter of 2011 to $3,973 million versus $3,841 million in the fourth quarter of 2010. For the full year 2011, total revenue increased 4% to $15,582 million from $15,053 million in 2010.
On December 15, 2011, Amgen (NASDAQ: AMGN) announced that its Board of Directors declared a $0.36 per share dividend for the first quarter of 2012.
On December 14, 2011, Amgen (NASDAQ: AMGN) announced final results of its modified Dutch auction tender offer, which expired on December 7, 2011.
On December 8, 2011, Amgen (OTC: AMGN) announced preliminary results of its modified Dutch auction tender offer, which expired at 12:00 midnight (EST) on December 7, 2011.
On November 7, 2011, Amgen (NASDAQ: AMGN) announced its plan to launch a modified Dutch auction tender offer to purchase up to $5 billion of its common stock, par value $0.0001 per share.
I don’t normally comment on individual stocks in this particular blog, but the MGIC situation represents a basic investment principle that is worthy of discussion here.
Read More.Price-to-Earnings ratios are probably the most widely used tool for comparing the relative values of different stocks.
Read More.This question comes up frequently when the market takes a dip.
Read More.Copyright © All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing.